Literature DB >> 1718278

Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma.

K Fujimoto1, Y Ichimori, T Kakizoe, E Okajima, H Sakamoto, T Sugimura, M Terada.   

Abstract

The serum level and urinary output of basic and acidic fibroblast growth factors (FGFs) were measured by sandwich enzyme immunoassay (EIA) in patients with renal cell carcinoma. In over fifty percent (16/31) of renal cell carcinoma patients, basic FGF was elevated (greater than 30 pg/ml) in their sera. There is relatively good correlation between serum levels of basic FGF and tumor stage or grade, while urinary daily output of basic FGF did not correlate with increased malignancy. The present results indicate that serum basic FGF level of patients with renal cell carcinoma is a useful diagnostic and prognostic marker for renal cell carcinoma. On the other hand, acidic FGF was not detectable in all sera and urine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718278     DOI: 10.1016/s0006-291x(05)81305-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  Antiangiogenic therapy in human gastrointestinal malignancies.

Authors:  J Heidemann; D G Binion; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

2.  Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.

Authors:  J W Slaton; K Inoue; P Perrotte; A K El-Naggar; D A Swanson; I J Fidler; C P Dinney
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 3.  Angiogenic factors as tumor markers.

Authors:  M Nguyen
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

Review 4.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

5.  Angiogenic capacity and lung-colonizing potential in vivo is increased in weakly metastatic B16F1 cells and decreased in highly metastatic BL6 cells by phorbol esters.

Authors:  C A La Porta; R Comolli
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

Review 6.  Antiangiogenesis as a novel therapeutic concept in pediatric oncology.

Authors:  L Schweigerer
Journal:  J Mol Med (Berl)       Date:  1995-10       Impact factor: 4.599

7.  Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.

Authors:  A R Perez-Atayde; S E Sallan; U Tedrow; S Connors; E Allred; J Folkman
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

8.  Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.

Authors:  H J Terpe; S Störkel; U Zimmer; V Anquez; C Fischer; K Pantel; U Günthert
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

9.  Clinical significance of fibroblast growth factor (FGF) expression in colorectal cancer.

Authors:  Norie Jibiki; Noboru Saito; Shingo Kameoka; Makio Kobayashi
Journal:  Int Surg       Date:  2014 Sep-Oct

10.  Novel methods for the determination of the angiogenic activity of human tumors.

Authors:  M Barbareschi; G Gasparini; L Morelli; S Forti; P Dalla Palma
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.